Literature DB >> 2424008

Phosphatidylinositol metabolism and polyoma-mediated transformation.

D R Kaplan, M Whitman, B Schaffhausen, L Raptis, R L Garcea, D Pallas, T M Roberts, L Cantley.   

Abstract

The effect of polyoma middle-sized tumor antigen (MTAg) on phosphatidylinositol metabolism has been characterized in vivo and in vitro using polyoma-transformed and polyoma-infected cells. Cells infected with transformation-competent polyoma virus exhibit increased levels of inositol phospholipids and the second messenger inositol trisphosphate. MTAg or pp60c-src immunoprecipitates from MTAg-transformed cells contain an activity that phosphorylates phosphatidylinositol and phosphatidylinositol 4-phosphate. This activity is induced in parallel with MTAg when the MTAg synthesis is regulated by hormonal or heavy metal inducers. Immunoprecipitates from one class of polyoma mutants defective in transformation have a reduced level of associated phosphatidylinositol kinase activity in vitro yet are capable of tyrosine phosphorylation on exogenous protein substrates at rates comparable to wild-type virus. Thus, for these mutants, phosphatidylinositol kinase activity is more tightly correlated with transformation than is protein kinase activity. These results suggest that alterations in phosphatidylinositol metabolism by MTAg play a role in transformation by polyoma virus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424008      PMCID: PMC323575          DOI: 10.1073/pnas.83.11.3624

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  Oncogenes, ions, and phospholipids.

Authors:  I G Macara
Journal:  Am J Physiol       Date:  1985-01

Review 2.  Inositol trisphosphate and diacylglycerol as second messengers.

Authors:  M J Berridge
Journal:  Biochem J       Date:  1984-06-01       Impact factor: 3.857

Review 3.  The role of protein kinase C in cell surface signal transduction and tumour promotion.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1984 Apr 19-25       Impact factor: 49.962

4.  Middle tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with pp60c-src.

Authors:  J B Bolen; M A Israel
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

5.  Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol.

Authors:  Y Sugimoto; M Whitman; L C Cantley; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Inositol trisphosphate formation and calcium mobilization in Swiss 3T3 cells in response to platelet-derived growth factor.

Authors:  M J Berridge; J P Heslop; R F Irvine; K D Brown
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

Review 7.  Inositol trisphosphate, a novel second messenger in cellular signal transduction.

Authors:  M J Berridge; R F Irvine
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

8.  Hydrolysis of polyphosphoinositides by purified sheep seminal vesicle phospholipase C enzymes.

Authors:  D B Wilson; T E Bross; S L Hofmann; P W Majerus
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

9.  Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation.

Authors:  J B Bolen; C J Thiele; M A Israel; W Yonemoto; L A Lipsich; J S Brugge
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

10.  Monoclonal antibodies to Rous sarcoma virus pp60src react with enzymatically active cellular pp60src of avian and mammalian origin.

Authors:  S J Parsons; D J McCarley; C M Ely; D C Benjamin; J T Parsons
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

View more
  80 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Interactions of polyomavirus middle T with the SH2 domains of the pp85 subunit of phosphatidylinositol-3-kinase.

Authors:  M Yoakim; W Hou; Y Liu; C L Carpenter; R Kapeller; B S Schaffhausen
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

3.  Functional asymmetry of the regions juxtaposed to the membrane-binding sequence of polyomavirus middle T antigen.

Authors:  J Dahl; U Thathamangalam; R Freund; T L Benjamin
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

4.  Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases.

Authors:  S B Kanner; A B Reynolds; R R Vines; J T Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

5.  Phosphatidylinositol kinase is activated in membranes derived from cells treated with epidermal growth factor.

Authors:  D H Walker; L J Pike
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

6.  Interactions between polyomavirus medium T antigen and three cellular proteins of 88, 61, and 37 kilodaltons.

Authors:  T Grussenmeyer; A Carbone-Wiley; K H Scheidtmann; G Walter
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

7.  Evidence for two distinct phosphatidylinositol kinases in fibroblasts. Implications for cellular regulation.

Authors:  M Whitman; D Kaplan; T Roberts; L Cantley
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

8.  Transcriptional regulation of early-response genes during polyomavirus infection.

Authors:  G M Glenn; W Eckhart
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

Review 9.  PI3K signaling in glioma--animal models and therapeutic challenges.

Authors:  Christine K Cheng; Qi-Wen Fan; William A Weiss
Journal:  Brain Pathol       Date:  2009-01       Impact factor: 6.508

10.  Interleukin 1 stimulates phosphatidylinositol kinase activity in human fibroblasts.

Authors:  L R Ballou; S C Barker; A E Postlethwaite; A H Kang
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.